1. "Adult Leukemia"
Formats
  1. Meeting Abstract (1737)
  2. Journal Article (1573)
  3. Review (118)
  4. Research Letter (52)
  5. Editorial (46)
  6. Book Section (39)
  7. Guidelines (19)
  8. Conference Paper (18)
  9. Correspondence (12)
  10. Miscellaneous (2)
  11. Book Whole (1)
Groups
  1. Adult Leukemia (3617)
  2. Center for Hematologic Malignancies (3617)
  3. Department of Medicine (3586)
  4. Hematologic Malignancies, Division of (3582)
  5. GSK Faculty (1754)
  6. Executive Committee, Center for Hematologic Malignancies (948)

More Groups

People
  1. Ross Levine (774)
  2. Martin Tallman (649)
  3. David Scheinberg (499)
  4. Jae Park (356)
  5. Eytan Stein (341)
  6. Raajit Rampal (338)

More People

Years
  1. 2025 (51)
  2. 2024 (145)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1200)
  2. Journal of Clinical Oncology (214)
  3. Clinical Lymphoma, Myeloma and Leukemia (116)
  4. Leukemia (108)
  5. Haematologica (106)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1289)
  2. Nature Publishing Group (317)
  3. Elsevier Inc. (256)
  4. American Association for Cancer Research (232)
  5. American Society of Clinical Oncology (225)
  6. Ferrata Storti Foundation (106)

More Publishers

Results (3617)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes through cytokine feed forward mechanisms
    Meeting Abstract

    Mathias, M. D.; Sockolosky, J. T.; Chang, A. Y. Y.; Liu, C.; Garcia, K. C.; Scheinberg, D. A.
    Blood (2016)

    Fulltext@MSK | Save
  • The development of a qPCR assay for the evaluation of the dendritic cell chimeric antigen receptor transcriptome
    Meeting Abstract

    Leyfman, Y.; Daniyan, A.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Treatment-related infections and risk factors in patients with myeloproliferative neoplasms treated with ruxolitinib
    Meeting Abstract

    King, A. C.; Hsu, M.; Mauro, M. J.; Rampal, R. K.
    Blood (2016)

    Fulltext@MSK | Save
  • Long-term follow-up of the efficacy and safety of ponatinib in Philadelphia chromosome-positive leukemia patients with the T315I mutation
    Meeting Abstract

    Jabbour, E. J.; Cortes, J. E.; Talpaz, M.; Baccarani, M.; Mauro, M. J.; Hochhaus, A.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Shah, N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase I trial of targeted alpha-particle therapy with Actinium-225 ((225)Ac)-lintuzumab and low-dose cytarabine (LDAC) in patients age 60 or older with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Levy, M. Y.; Park, J. H.; Ravandi, F.; Perl, A. E.; Pagel, J. M.; Smith, B. D.; Estey, E. H.; Kantarjian, H.; Cicic, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Novel associations between mutations, prognostic and clinical parameters in untreated progressive CLL: Data from E1912, a randomized phase III study of the ECOG-ACRIN Cancer Research Group
    Meeting Abstract

    Braggio, E.; Wang, V. X.; Garcia, S.; Bruins, L. A.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Fonseca, R.; Kay, N. E.; more...
    Blood (2016)

    Fulltext@MSK | Save